- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$2.86 BnMarket Estimate, 2026
$3.09 BnMarket Forecast, 2034
$5.68 BnCAGR, 2026–2034
7.9%North America Needles Market Report Summary
The North America needles market was valued at USD 2.86 billion in 2025 and is projected to reach USD 5.68 billion by 2034, growing at a CAGR of 7.9% during the forecast period from 2026 to 2034. The growth of the North America needles market is driven by the rising demand for vaccines, the increasing geriatric population, and the growing prevalence of chronic diseases such as diabetes. Expanding hospital infrastructure, increasing adoption of injectable therapies, and rising awareness regarding blood donation are further supporting market growth. Moreover, technological advancements in needle safety, precision, and ease of use, along with the growing trend of self-administration of drugs, are broadening the application scope of needles across healthcare settings in North America.
Key Market Trends
- Increasing demand for safety needles to reduce needlestick injuries among healthcare professionals.
- Rising use of pen needles and insulin delivery devices due to the growing diabetic population.
- Growing adoption of self-injection devices for chronic disease management and home healthcare.
- Technological advancements leading to high-precision and minimally painful needle designs.
- Expansion of point-of-care diagnostics and vaccination programs driving needle consumption.
Segmental Insights
- Based on type, the conventional needles segment held the largest share of the North America needles market in 2024. The dominance of this segment is attributed to their widespread use in hospitals and clinics for routine injections, blood collection, and vaccination procedures.
- Based on product, the suture needles segment accounted for the leading share of the North America needles market in 2024. This dominance is driven by the high volume of surgical procedures, increasing trauma cases, and the expanding number of outpatient and inpatient surgeries across the region.
- Based on material, the stainless-steel needles segment represented one of the most lucrative segments of the North America needles market. The segment’s growth is supported by the material’s durability, corrosion resistance, cost-effectiveness, and suitability for repeated clinical use.
- Based on end user, the hospitals and clinics segment occupied a dominant share of the North America needles market in 2024. The segment’s leadership is attributed to the high patient inflow, availability of skilled healthcare professionals, and the large number of diagnostic, therapeutic, and surgical procedures performed in hospital settings.
Regional Insights
The North America needles market is witnessing steady growth across the region due to a well-established healthcare infrastructure, increasing healthcare expenditure, and the presence of major medical device manufacturers.
- The United States dominated the North America needles market in 2024, driven by the high prevalence of diabetes, strong reimbursement frameworks, extensive vaccination programs, and continuous technological advancements in injection devices.
- Canada followed the United States and is expected to witness healthy growth during the forecast period, supported by rising healthcare awareness, increasing chronic disease burden, and expanding access to medical services.
Competitive Landscape
The North America needles market is characterized by the presence of established global manufacturers with strong distribution networks and extensive product portfolios. Leading companies are focusing on product innovation, safety-enhanced needle designs, and strategic partnerships to strengthen their market presence. Increased investments in research and development and the introduction of advanced safety needles are key competitive strategies. Prominent players operating in the North America needles market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific.
North America Needles Market Size
The North America needles market was valued at USD 2.86 billion in 2025, is estimated to reach USD 3.09 billion in 2026, and is projected to reach USD 5.68 billion by 2034, growing at a CAGR of 7.9% from 2026 to 2034.
The growing demand for vaccines, the increasing geriatric population, and a growing number of hospitals in North America majorly drive the needles market growth in North America. In addition, the demand for needles in the North American region is expected to be fuelled by the rising prevalence of chronic diseases such as diabetes. Around 425 million people had diabetes worldwide in 2018; by 2045, this number is expected to reach 640 million (Source: International Diabetes Federation). According to the data published by the IDF Diabetes Atlas, an estimated 51 million had diabetes in North America and the Caribbean, and this number is expected to grow to 57 million by 2030 and 63 million by 2045. As per the same source, one in every seven people had diabetes in North America and the Caribbean, and 931,000 died of diabetes in 2021. Therefore, with the increasing prevalence of diabetes globally, the demand for needles will increase during the forecast period.
In addition, several biotechnology and pharmaceutical companies are dedicated to developing new injectable drugs useful in treating chronic diseases, increasing the production of needles, and thus driving the market growth rate. The North American needles market is expected to experience significant growth, owing to increased people's awareness about donating blood, extensive R&D, which has introduced new needle technology with high safety and precision, and the growing demand for point-of-care diagnostics. In addition, the increase in the self-administration of drugs and the increasing use of safety needles will provide opportunities for market growth during the forecast period.
However, the increase in needlestick injuries and infections, the use of needle-free technology, and the growing attention to developing alternative drug delivery methods are the main factors expected to slow the market's growth. In addition, the factors limiting the growth of the market are the lack of qualified physicians and the anxiety related to needles. The North American needles market is further expected to face some challenges due to the reuse of needles, complications and mental factors associated with needles, the availability of other convenient dosage forms such as those administered orally, and poor health care reimbursement policies in developing and underdeveloped regions.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 7.9% |
| Segments Covered | By Product, Delivery Mode, Material, End User and Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | U.S, Canada, Rest of North America |
| Market Leaders Profiled | Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, and Smiths Medical, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific. |
SEGMENTAL ANALYSIS
By Type Insights
Based on type, the conventional needles segment had a major share of the North American needles market in 2025.
By Product Insights
Based on product, the suture needles segment held the leading share of the North American market in 2025.
By Material Insights
The stainless-steel needles segment is one of the most lucrative in the North American market and is forecasted to witness a healthy CAGR in the coming years.
By End User Insights
The hospitals and clinics segment is anticipated to hold a leading share of the North American market in 2025.
REGIONAL ANALYSIS
The North American region accounted for the most significant global market share in 2024. The North American region is estimated to continue holding the largest global market share during the forecast period owing to factors such as the presence of a well-established healthcare infrastructure, increasing R&D activities by the market participants to bring new and effective products to the market, and the presence of several pharmaceutical, medical devices, and biotechnological companies. The U.S. led the needles market in the North American market, followed by Canada.
The U.S is expected to have a dominant share over Canada in the North American market during the forecast period. The growth of the U.S. needles market is primarily driven by the rising prevalence of diabetes and the presence of favorable reimbursement scenarios for needles; federal injection technology awareness initiatives, increased market penetration of major companies, and improved needle technologies are driving forward market growth in the U.S. Growing demand for healthcare, driven by the rapid aging of the population, increasing prevalence of diabetes and other chronic diseases, is driving the growth of the U.S. needles market. As a result, the value of the North American needles market is expected to grow slightly during the forecast period.
During the forecast period, the Canadian market is anticipated to hold a considerable share of the North American market and witness a healthy CAGR.
KEY MARKET PLAYERS
Some of the companies that are dominating the North American Needles market include
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Terumo Corporation
- Smiths Medical
- Thermo Fisher Scientific
MARKET SEGMENTATION
This research report on the North America Needles Market has been segmented and sub-segmented into the following categories.
By Type
- Conventional Needles
- Bevel Needles
- Blunt Fill Needles
- Filter Needles
- Vented Needles
- Safety Needles
- Active Needles
- Passive Needles
By Product
- Suture Needles
- Blood Collection Needles
- Ophthalmic Needles
- Dental Needles
- Insufflation Needles
- Pen Needles
- Other Needles
By Delivery Mode
- Hypodermic Needles
- Intravenous Needles
- Intramuscular Needles
- Intraperitoneal Needles
By Material
- Stainless Steel Needles
- Plastic Needles
- Glass Needles
- PEEK Needles
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Home Healthcare
By Country
- The United States
- Canada
- Rest of North America